Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
Journal of the International AIDS Society | July 2017

Globally, there is a considerable burden of HCV and HIV infections among people who inject drugs (PWID) and transmission of both infections continues. Needle and syringe programme (NSP) and opioid substitution therapy (OST) coverage remains low, despite evidence demonstrating their prevention benefit.

Read more